Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

PHA 057 SAS #6 Summary of drugs

Total questions: 62

Worksheet time: 1hrs 2mins

Name
Class
Date
1.

Give 2 Rapid acting insulin:

(a)  

2.

Give short-acting insulin:

(a)  

3.

Give Intermediate acting Insulin:

(a)  

4.

Give 2 Long-acting insulin:

(a)  

5.

MOA of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec:

(a)  

6.

Drug classification of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec:

(a)  

7.

Clinical Applications of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec:

(a)  

8.

Adverse effects of Lispro, Aspart, Glusiline, Aspart+Niacinamide, NPH, Detemir, Glargine, Deglunec (INSULINS):

(a)  

9.

Give 2 drugs classified as Sulfonylureas:

(a)  

10.

Drug classification of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide:

(a)  

11.

MOA of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide:

(a)  

12.

Clinical application of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide:

(a)  

13.

Adverse effects of Glipizide, Glyburide, Glimepiride, Gliclazide, Tolazamide, Tolbutamide, Chlorpropamide, Acetohexamide (Sulfonylureas):

(a)  

14.

GIve 2 examples of Meglitinide Analogs; D-Phenylanaline Derivative

(a)  

15.

Drug classification of Repaglinide, Nateglinide, and Mitiglinide

(a)  

16.

MOA of Repaglinide, Nateglinide, and Mitiglinide:

(a)  

17.

Clinical Application of Repaglinide, Nateglinide, and Mitiglinide:

(a)  

18.

Adverse effect of Repaglinide, Nateglinide, and Mitiglinide

(a)  

19.

Give example of Biguanides

(a)  

20.

Drug classification of Metformin:

(a)  

21.

MOA of Metformin:

(a)  

22.

Clinical Application of Metformin:

(a)  

23.

Give 2 adverse effects of Metformin (Biguanides):

(a)  

24.

Give 2 example of Alpha-Glucosidase Inhibitors:

(a)  

25.

Drug classification of Voglibose, Acarbose,a nd Miglitol:

(a)  

26.

MOA of Voglibose, Acarbose,a nd Miglitol:

(a)  

27.

Clinical Application of Voglibose, Acarbose,a nd Miglitol:

(a)  

28.

Give 2 examples of Thiazolidinediones:

(a)  

29.

Drug classification of Pioglitazone and Rosiglitazone:

(a)  

30.

Clinical Application of Pioglitazone and Rosiglitazone:

(a)  

31.

Adverse effect of Pioglitazone and Rosiglitazone (Thiazolidinediones):

(a)  

32.

Give 2 example of Glucagon-like Polypeptide-1 (GLP-1) Receptor Agonists:

(a)  

33.

Drug classification of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide:

(a)  

34.

MOA of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide:

(a)  

35.

Clinical Application of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide:

(a)  

36.

Clinical Application of Liraglutide:

(a)  

37.

Adverse effect of Semaglutide, Lixisenatide, Liraglutide, Exenatide, Dulaglutide (Glucagon-like Polypeptide-1 (GLP-1) Receptor Agonists):

(a)  

38.

Give 2 example of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors:

(a)  

39.

Drug classification of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin:

(a)  

40.

MOA of of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin:

(a)  

41.

Clinical Application of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin:

(a)  

42.

Adverse effect of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors):

(a)  

43.

Give 2 example of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors:

(a)  

44.

Drug classification of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin:

(a)  

45.

MOA of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin:

(a)  

46.

Clinical Application of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin:

(a)  

47.

Adverse effect of Canagflozin, Dapagliflozin, Empagflozin, Ertugliflozin (Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors):

(a)  

48.

Give example of Islet Amyloid Polypepetide Analog:

(a)  

49.

MOA of Pramlintide

(a)  

50.

Drug classification of Pramlintide:

(a)  

51.

Clinical Application of Pramlintide:

(a)  

52.

Adverse effect Pramlintide (Islet Amyloid Polypepetide Analog);

(a)  

53.

Give example of Bile Acid Sequestrant:

(a)  

54.

Drug classification of Colesevelam hydrochloride:

(a)  

55.

MOA of Colesevelam hydrochloride:

(a)  

56.

Clinical Application of Colesevelam hydrochloride:

(a)  

57.

Adverse effect of Colesevelam hydrochloride:

(a)  

58.

Give example of Dopamine Agonist:

(a)  

59.

Drug classification of Bromocriptine:

(a)  

60.

MOA of Bromocriptine:

(a)  

61.

Clinical Application of Bromocriptine:

(a)  

62.

Adverse effect of Bromocriptine ( Dopamine Agonists):

(a)